The US Food and Drug Administration (FDA) is warning healthcare providers about potential hazards from interactions between implanted programmable cerebrospinal fluid (CSF) shunts and hearing implants ...
Custom Safety Update image Individuals with an implantable programmable cerebrospinal fluid shunt are at risk for unintended changes to valve settings through exposure to magnetic fields present in ...
Oct. 21, 2002 — Low-flow cerebroventricular shunting may be worth investigating further in Alzheimer's disease, according to the authors of a pilot study reported in the Oct. 22 issue of Neurology.
Direct Translation of a Protracted Irinotecan Schedule From a Xenograft Model to a Phase I Trial in Children PURPOSE: Leptomeningeal disease (LMD) significantly affects the prognosis and treatment of ...
The global cerebrospinal fluid (CSF) management market is expected to reach USD 1.56 Billion by 2022. The global cerebrospinal fluid (CSF) management market is expected to reach USD 1.56 Billion by ...
Cerebrospinal fluid (CSF) shunts are implantable devices inserted by neurosurgeons to treat hydrocephalus. Shunt insertion and revision are the operations most commonly performed by pediatric ...
Background: The rate of repeat shunt-related cerebrospinal fluid (CSF) infections and the contributing risk factors were analyzed. Methods: Our clinic treated 58 children for initial shunt ...
The typical signs and symptoms of idiopathic NPH are shown. In a retrospective study involving 418 patients with shunt-responsive idiopathic NPH, 96% of the patients had gait difficulty, 76% had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results